Loading...
XSHG
600713
Market cap973mUSD
Jul 10, Last price  
5.09CNY
1D
0.79%
1Q
-15.87%
Jan 2017
-35.97%
Name

NanJing Medical Company Limited

Chart & Performance

D1W1MN
XSHG:600713 chart
P/E
10.66
P/S
0.12
EPS
0.48
Div Yield, %
3.37%
Shrs. gr., 5y
7.06%
Rev. gr., 5y
6.66%
Revenues
54.96b
+2.36%
6,827,704,0009,344,858,00011,396,288,00014,025,514,00015,337,627,00017,171,694,00018,024,220,36719,235,934,45422,075,780,80724,813,087,31726,720,500,72728,810,266,44331,303,046,29337,155,742,31839,817,363,61145,123,195,14350,221,563,81253,589,664,72753,696,173,89554,963,277,449
Net income
625m
+9.50%
10,887,00046,680,00030,335,00046,242,0009,374,000-182,617,00010,820,43938,680,662128,880,149156,724,469180,271,841232,442,424264,293,788346,920,160376,413,118505,182,818595,667,812577,825,653570,627,558624,834,794
CFO
92m
-95.70%
161,314,00081,080,0004,327,00020,217,000119,077,000-692,530,000168,168,000-354,268,000-341,014,000-306,084,000-240,878,000319,988,000-366,902,0001,003,955,000-1,152,463,000695,331,000-682,313,0001,906,405,0002,135,765,00091,808,928
Dividend
Jun 30, 20250.17 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Established in 1951 and headquartered in Nanjing, China, NanJing Pharmaceutical Company Limited specializes in the nationwide wholesale and retail distribution of pharmaceutical products. The company oversees a substantial network comprising approximately 510 physical pharmacy outlets, alongside an active e-commerce platform for online sales.
URL
https://www.njyy.com/
IPO date
Jul 01, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT